Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
US Army
Merck
QuintilesIMS
Express Scripts
Fish and Richardson
Julphar
UBS
Harvard Business School
Baxter

Generated: February 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,562,829

« Back to Dashboard

Summary for Patent: 4,562,829
Title: Strontium-rubidium infusion system
Abstract:The strontium-rubidium infusion system includes means for generating a solution containing rubidium-82, measuring the radioactivity in the solution, and infusing it into a patient in order to perform various studies on the patient's heart. The system includes a wash syringe which can be used by a physician to manually inject a bolus containing a large amount of radioactivity directly into a patient in order to perform first pass ventriculography studies.
Inventor(s): Bergner; Brian C. (Lawrenceville, NJ)
Assignee: E. R. Squibb & Sons, Inc. (Princeton, NJ)
Application Number:06/605,758
Patent Claim Types:
see list of patent claims
Formulation;

Drugs Protected by US Patent 4,562,829

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,562,829

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 53305 ➤ Sign Up
Australia 2464684 ➤ Sign Up
Australia 4186285 ➤ Sign Up
Australia 570429 ➤ Sign Up
Australia 581218 ➤ Sign Up
Canada 1233274 ➤ Sign Up
Canada 1237539 ➤ Sign Up
Canada 1250504 ➤ Sign Up
Germany 3482410 ➤ Sign Up
Germany 3581653 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Cantor Fitzgerald
Merck
Moodys
Chubb
Cerilliant
Teva
Cipla
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot